Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Raschack, M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 20 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hocher, B; Schwarz, A; Reinbacher, D; Jacobi, J; Lun, A; Priem, F; Bauer, C; Neumayer, HH; Raschack, M
      Effects of endothelin receptor antagonists on the progression of diabetic nephropathy

      NEPHRON
    2. Orth, SR; Amann, K; Gehlen, F; Unger, L; Wagner, J; Raschack, M; Ritz, E
      Adult human mesangial cells (HMCs) express endothelin-B-receptors which mediate endothelin-1-induced cell growth

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    3. Merkely, B; Szabo, T; Geller, L; Kiss, O; Horkay, F; Raschack, M; Juhasz-Nagy, A
      The selective endothelin-A-receptor antagonist LU 135.252 inhibits the direct arrhythmogenic action of endothelin-1

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    4. Kiss, O; Geller, L; Merkely, B; Szabo, T; Raschack, M; Seres, L; Zima, E; Juhasz-Nagy, A; Horkay, F
      Endothelin-A-receptor antagonist LU 135.252 inhibits the formation of ventricular arrhythmias caused by intrapericardial infusion of endothelin-1

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    5. Dhein, S; Hochreuther, S; Spring, CAD; Bollig, K; Hufnagel, C; Raschack, M
      Long-term effects of the endothelin(A) receptor antagonist LU 135252 and the angiotensin-converting enzyme inhibitor trandolapril on diabetic angiopathy and nephropathy in a chronic type I diabetes mellitus rat model

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    6. Orth, SR; Odoni, G; Amann, K; Strzelczyk, P; Raschack, M; Ritz, E
      The ETA receptor blocker LU 135252 prevents chronic transplant nephropathyin the "Fisher to Lewis" model

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    7. ORTH SR; ESSLINGER JP; AMANN K; SCHWARTZ U; RASCHACK M; RITZ E
      DIETARY SALT - EFFECT ON RENAL DAMAGE AND NEPHROPROTECTIVE EFFECT OF THE ETA-RECEPTOR ANTAGONIST LU-135252 IN UNINEPHRECTOMIZED (UNX) SHRSPRATS

      Hypertension
    8. ORTH SR; ESSLINGER JP; AMANN K; SCHWARZ U; RASCHACK M; RITZ E
      NEPHROPROTECTION OF AN ETA-RECEPTOR BLOCKER (LU-135252) IN SALT-LOADED UNINEPHRECTOMIZED STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS

      Hypertension
    9. RASCHACK M; ROZEKSCHAFER G; RIECHERS H; JUCHELKA F
      ENDOTHELIN (ETA) ANTAGONISM IS AN EFFECTIVE ANTIARRHYTHMIC AND ANTIFIBRILLATORY PRINCIPLE IN ISCHEMIC PIG HEARTS AND PREVENTS HYPOXIC UNCOUPLING IN PAPILLARY-MUSCLES

      Naunyn-Schmiedeberg's archives of pharmacology
    10. RASCHACK M; HERGENRODER S; UNGER L; HAHN A; AMBERG W; GOCK S; ALKEN P; WEBER A
      THE NEW ETA B RECEPTOR ANTAGONIST LU-302872 SHOWS HIGH ORAL ACTIVITY AND INHIBITS HUMAN PROSTATE CONTRACTIONS/

      The Journal of urology
    11. ORTH SR; ESSLINGER JP; AMANN K; SCHWARZ U; RASCHACK M; RITZ E
      NEPHROPROTECTIVE EFFECT OF THE ETA-RECEPTOR ANTAGONIST LU-135252 IN SALT-LOADED UNINEPHRECTOMIZED (UNX) STROKE-PRONE HYPERTENSIVE RATS (SHRSP)

      Journal of the American Society of Nephrology
    12. HOCHER B; STUMPF C; LUN A; RASCHACK M; NEUMAYER HH
      THE PARACRINE ET SYSTEM IN DIABETES - COMPARISON OF ACE-INHIBITION AND ETA ANTAGONISM

      Journal of the American Society of Nephrology
    13. HOCHER B; THONEREINEKE C; BAUER C; RASCHACK M; NEUMAYER HH
      THE PARACRINE ENDOTHELIN SYSTEM - PATHOPHYSIOLOGY AND IMPLICATIONS INCLINICAL MEDICINE

      European journal of clinical chemistry and clinical biochemistry
    14. STUMPF C; GOECK S; UNGER L; NEBEL M; RIECHERS H; RASCHACK M
      LU-135-252 SHOWS HIGH ENDOTHELIN-A RECEPTOR AFFINITY AND SELECTIVITY AND ORAL EFFICACY LEADING TO REDUCTION OF NEOINTIMA FORMATION IN COLLARED RABBIT CAROTID ARTERIES

      Naunyn-Schmiedeberg's archives of pharmacology
    15. HELD HD; RASCHACK M; UHLIG S
      ROLE OF ENDOTHELIN-CONVERTING ENZYME AND NEUTRAL ENDOPEPTIDASE-24.11 FOR BIG ENDOTHELIN-1-INDUCED BRONCHOCONSTRICTION AND VASOCONSTRICTION IN PERFUSED RAT LUNG

      Naunyn-Schmiedeberg's archives of pharmacology
    16. RIECHERS H; ALBRECHT HP; AMBERG W; BAUMANN E; BERNARD H; BOHM HJ; KLINGE D; KLING A; MULLER S; RASCHACK M; UNGER L; WALKER N; WERNET W
      DISCOVERY AND OPTIMIZATION OF A NOVEL CLASS OF ORALLY-ACTIVE NONPEPTIDIC ENDOTHELIN-A RECEPTOR ANTAGONISTS

      Journal of medicinal chemistry
    17. ORTH SR; UNGER L; RASCHACK M; RITZ E
      ADULT HUMAN MESANGIAL CELLS (HMC) EXPRESS ATYPICAL ENDOTHELIN SUBTYPE-B (ET(B)) RECEPTORS

      Journal of the American Society of Nephrology
    18. RASCHACK M; UNGER L; RIECHERS H; KLINGE D
      RECEPTOR SELECTIVITY OF ENDOTHELIN ANTAGONISTS AND PREVENTION OF VASOCONSTRICTION AND ENDOTHELIN-INDUCED SUDDEN-DEATH

      Journal of cardiovascular pharmacology
    19. TOFFOLI G; SIMONE F; CORONA G; RASCHACK M; CAPPELLETTO B; GIGANTE M; BOIOCCHI M
      STRUCTURE-ACTIVITY RELATIONSHIP OF VERAPAMIL ANALOGS AND REVERSAL OF MULTIDRUG-RESISTANCE

      Biochemical pharmacology
    20. ELGER B; SEEGA J; RASCHACK M
      EDEMA REDUCTION BY LEVEMOPAMIL IN FOCAL CEREBRAL-ISCHEMIA OF SPONTANEOUSLY HYPERTENSIVE RATS STUDIED BY MAGNETIC-RESONANCE-IMAGING

      European journal of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 15:13:34